查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1650329

2025 年全球醫療奈米技術市場報告

Healthcare Nanotechnology Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年醫療奈米技術的市場規模將快速成長。到 2029 年，這一數字將成長至 7,231.8 億美元，複合年成長率為 16.8%。預測期內的成長可歸因於治療診斷學、基因治療奈米粒子、生物相容性奈米材料、奈米手術器械、奈米治療學和全球衛生緊急情況應對方面的發展。預測期內的主要趨勢包括診斷奈米設備、生物感測器和成像、奈米機器人和奈米手術、個人化醫療以及公眾意識和教育治療應用。

癌症發生率的上升預計將推動醫療奈米技術市場的成長。奈米技術是一種很有前途的癌症治療方法，為包括癌症在內的多種疾病提供了更個人化的治療可能性。全球癌症發生率持續上升。例如，美國癌症協會估計，2023年美國將有1,958,310例新發癌症病例和609,820例癌症相關死亡病例。這些統計數據表明，儘管醫療技術和早期檢測方法不斷進步，但預防和治療癌症的挑戰仍然存在。這些統計數據凸顯了持續研究和有效的醫療保健策略以有效應對癌症的迫切需求。因此，癌症患者數量的增加正在刺激醫療奈米技術市場的成長。

糖尿病和肥胖症的增加預計將推動醫療保健奈米技術市場的未來成長。糖尿病是血糖值過高時發生的疾病，而肥胖則定義為 BMI 為 30 或更高。醫療奈米技術提供有針對性的藥物傳遞和精準醫療方法來治療糖尿病和肥胖症，提高治療效果同時最大限度地減少副作用。例如，總部位於比利時的國際糖尿病聯盟報告稱，到2022年6月，全球糖尿病盛行率將上升至10.5%，其中一半以上（44.7%）的人仍未得到診斷。 IDF 預測，到 2045 年，全球將有 7.83 億成年人（即每八人中就有一人）患有糖尿病。這一成長幅度為 46%，是同期預期人口成長率（20%）的兩倍多。此外，瑞士世界衛生組織（WHO）在2022年3月預測，全球將有6.5億成年人、3.4億青少年和3,900萬名兒童肥胖。世界衛生組織預測，到2025年，將有1.67億成人和兒童超重或肥胖。因此，糖尿病和肥胖症的增加正在推動醫療保健奈米技術市場的成長。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球醫療奈米技術市場的 PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素、限制因素）
  • 最終用途產業分析
  • 全球醫療奈米技術市場成長率分析
  • 全球醫療奈米技術市場表現：規模與成長，2019 年至 2024 年
  • 全球醫療奈米技術市場預測：規模與成長，2024-2029 年，2034 年
  • 全球醫療奈米技術總目標市場 (TAM)

第6章 市場細分

  • 全球醫療奈米技術市場（按疾病、表現和預測），2019-2024、2024-2029、2034
  • 心血管疾病
  • 腫瘤疾病
  • 神經系統疾病
  • 整形外科疾病
  • 感染疾病
  • 全球醫療奈米技術市場類型、表現與預測，2019-2024、2024-2029、2034
  • 有機的
  • 無機
  • 碳基
  • 全球醫療奈米技術市場的應用、性能和預測，2019-2024、2024-2029、2034
  • 藥物輸送
  • 生物材料
  • 主動植入
  • 組織再生
  • 全球醫療奈米技術市場：心血管疾病細分類型、表現與預測，2019-2024、2024-2029、2034
  • 藥物輸送系統
  • 影像診斷
  • 全球醫療奈米技術市場：腫瘤疾病細分類型、表現與預測，2019-2024、2024-2029、2034
  • 靶向藥物輸送
  • 基於奈米粒子的治療方法
  • 影像診斷
  • 全球醫療奈米技術市場：神經系統疾病細分類型、表現與預測，2019-2024、2024-2029、2034
  • 基於奈米顆粒的藥物輸送
  • 診斷工具
  • 全球醫療奈米技術市場：整形外科疾病細分類型、表現與預測，2019-2024、2024-2029、2034
  • 骨再生和修復
  • 藥物輸送系統
  • 全球醫療奈米技術市場：感染疾病細分類型、表現與預測，2019-2024、2024-2029、2034
  • 抗菌奈米材料
  • 疫苗輸送系統

第7章 區域和國家分析

  • 全球醫療奈米技術市場各地區、績效及預測，2019-2024、2024-2029、2034
  • 全球醫療奈米技術市場（按國家/地區分類）、表現和預測，2019-2024、2024-2029、2034

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第 17 章 德國市場

第 18 章 法國市場

第 19 章：義大利市場

第 20 章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第 25 章：加拿大市場

第26章 南美洲市場

第 27 章：巴西市場

第28章 中東市場

第 29 章：非洲市場

第 30 章競爭格局與公司概況

  • 醫療奈米科技市場：競爭格局
  • 醫療奈米技術市場：公司簡介
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Johnson & Johnson Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Merck & Company Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Union Chimique Belge S. A Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Teva Pharmaceutical Industries Ltd.
  • Sanofi SA
  • Taiwan Liposome Company Ltd.
  • GE Healthcare Technologies Inc.
  • Mallinckrodt plc
  • Leadiant Biosciences
  • Luminex Corporation
  • Bristol-Myers Squibb Company
  • CytImmune Sciences Inc.
  • Nanobiotix
  • Starpharma Holdings Limited
  • Copernicus Therapeutics Inc.
  • NanoCarrier Co. Ltd
  • LiPlasome Pharma ApS
  • Nami Therapeutics Corp.

第 32 章 全球競爭基準化分析與儀錶板

第33章 重大併購

第 34 章 近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029 年醫療保健奈米技術市場 - 提供最多新機會的國家
  • 2029 年醫療保健奈米技術市場 - 提供最新興機會的細分市場
  • 醫療保健奈米技術市場 2029-成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第 36 章 附錄

簡介目錄
Product Code: r21584

Healthcare nanotechnology refers to the area of science that combines nanotechnology with drugs or diagnostic molecules to improve the performance of specific cells or tissues. These materials are produced on a nanoscale level and are safe to inject into the body. Nanotechnologies can greatly enhance medical diagnostics by making them more affordable and practical.

The main types of healthcare nanotechnology include organic, inorganic, and carbon-based. Healthcare nanotechnology is used for various diseases such as cardiovascular, oncological, neurological, orthopedic, and infectious diseases. The main applications of healthcare nanotechnology include drug delivery, biomaterials, active implants, and tissue regeneration.

The healthcare nanotechnology market research report is one of a series of new reports from The Business Research Company that provides healthcare nanotechnology market statistics, including healthcare nanotechnology industry global market size, regional shares, competitors with healthcare nanotechnology market share, detailed healthcare nanotechnology market segments, market trends and opportunities, and any further data you may need to thrive in the healthcare nanotechnology industry. This healthcare nanotechnology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The healthcare nanotechnology market size has grown rapidly in recent years. It will grow from $344.23 billion in 2024 to $389.11 billion in 2025 at a compound annual growth rate (CAGR) of 13.0%. The growth in the historic period can be attributed to advancements in nanomaterials, nanomedicine research, regulatory support, investment in research and development, nanostructured biomaterials.

The healthcare nanotechnology market size is expected to see rapid growth in the next few years. It will grow to $723.18 billion in 2029 at a compound annual growth rate (CAGR) of 16.8%. The growth in the forecast period can be attributed to theranostics development, nanoparticles for gene therapy, biocompatible nanomaterials, nano-enabled surgical tools, nanoscale therapeutic agents, global health emergency preparedness. Major trends in the forecast period include diagnostic nanodevices, biosensors and imaging, nanorobotics and nanosurgery, personalized medicine, public awareness and education therapeutic applications.

The rising incidence of cancer cases is anticipated to drive the growth of the healthcare nanotechnology market. Nanotechnology represents a promising approach to cancer treatment, offering the potential for more personalized therapies for various diseases, including cancer. The global prevalence of cancer continues to rise. For example, in 2023, the American Cancer Society estimated that there would be 1,958,310 new cancer diagnoses and 609,820 cancer-related deaths in the United States. These statistics underscore the persistent challenges in cancer prevention and treatment, despite advancements in medical technology and early detection methods. They highlight the urgent need for ongoing research and effective healthcare strategies to address cancer effectively. Consequently, the increasing number of cancer cases is fueling the growth of the healthcare nanotechnology market.

Growing incidences of diabetes and obesity are expected to propel the growth of the healthcare nanotechnology market going forward. Diabetes refers to a condition that develops when blood glucose levels are too high, and obesity refers to the condition of having a body mass index of 30 or more. Healthcare nanotechnology offers targeted drug delivery and precision medicine approaches to manage diabetes and obesity, improving treatment efficacy while minimizing side effects. For instance, in June 2022, according to the International Diabetes Federation, a Belgium-based diabetes federation, the prevalence of diabetes had increased to 10. 5% worldwide, with over half (44. 7%) of people still undiagnosed. According to IDF predictions, 783 million adults, or one in eight people, will have diabetes by 2045. This would represent a 46% rise, more than double the projected population growth for the same period (20%). Furthermore, in March 2022, according to the World Health Organization, a Switzerland-based agency, 650 million adults, 340 million teenagers, and 39 million children will be obese. This quantity is still rising, and the WHO predicts that by 2025, 167 million adults and children will become overweight or obese. Therefore, growing incidences of diabetes and obesity are driving the growth of the healthcare nanotechnology market.

Strategic collaboration between companies is a key trend gaining popularity in the healthcare nanotechnology market. Companies involved in healthcare nanotechnologies are undergoing partnerships and collaboration to develop new technologies and products. In January 2022, NaNotics, a US-based medical company, collaborated with the Mayo Clinic to develop a cancer treatment known as NaNots. The collaboration will involve NaNotics sharing its nano-depletion platform with Mayo researchers, while the Mayo Clinic will provide its own PD-L1 antibody and a transgenic mouse model that provides human sPD-L1. Mayo Clinic is a US-based clinic dedicated to providing patient care, education, and research in various fields of medicine, including nanomedicine.

Major companies operating in the healthcare nanotechnology market are increasing their focus on introducing nanotechnology-based gel serums to gain a competitive edge in the market. Nanotechnology-based gel serums are products that incorporate nanoscale particles or delivery systems to enhance the absorption and effectiveness of active ingredients. For instance, in March 2023, ENTOD Pharmaceuticals, an India-based healthcare company, launched Eyecirque, a nanotechnology-based under-eye product, in India. Eyecirque is formulated with a cutting-edge, 100% plant-based biocellular composition, featuring vitamin A, C, and E complexes, anti-aging antioxidants, skin-brightening agents, and naturally occurring ultra-moisturizing elements that are rapidly absorbed into the skin around the eyes at a nano-molecular level. It stands as the world's first gel serum of its kind, utilizing nanotechnology to address concerns such as wrinkles, hollowness, hollow eyelids, and dark circles under the eyes.

In January 2024, GenEdit, Inc., a US-based biotechnology firm, announced a multiyear collaboration and licensing agreement with Genentech to develop innovative nanoparticles for the delivery of genetic medicines intended to treat autoimmune diseases. This partnership will utilize GenEdit's NanoGalaxy platform, emphasizing the discovery of hydrophilic nanoparticles (HNPs) for nucleic acid-based therapies. Genentech, also based in the US, is a biotechnology corporation that specializes in healthcare nanotechnology.

Major companies operating in the healthcare nanotechnology market include Pfizer Inc., Johnson & Johnson Inc., Abbott Laboratories, Merck & Company Inc., Union Chimique Belge S. A, Teva Pharmaceutical Industries Ltd., Sanofi SA, Taiwan Liposome Company Ltd., GE Healthcare Technologies Inc., Mallinckrodt plc, Leadiant Biosciences, Luminex Corporation, Bristol-Myers Squibb Company, CytImmune Sciences Inc., Nanobiotix, Starpharma Holdings Limited, Copernicus Therapeutics Inc., NanoCarrier Co. Ltd, LiPlasome Pharma ApS, Nami Therapeutics Corp., Nanospectra Biosciences Inc., Spago Nanomedical AB, Nanobiosym Inc., Nanoviricides Inc., Nanosys Inc., Nanocarrier Co. Ltd., Nanocyl SA, Nanogen Pvt. Ltd.

North America was the largest region in the healthcare nanotechnology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the healthcare nanotechnology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the healthcare nanotechnology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The healthcare nanotechnology market includes revenues earned by entities by targeting tumors, in drug delivery systems, and improving medical imaging. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Healthcare Nanotechnology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on healthcare nanotechnology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for healthcare nanotechnology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The healthcare nanotechnology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Disease: Cardiovascular Diseases; Oncological Diseases; Neurological Diseases; Orthopedic Diseases; Infectious Diseases
  • 2) By Type: Organic; Inorganic; Carbon-Based
  • 3) By Application: Drug Delivery; Biomaterials; Active Implants; Tissue Regeneration
  • Subsegments:
  • 1) By Cardiovascular Diseases: Drug Delivery Systems; Diagnostic Imaging
  • 2) By Oncological Diseases: Targeted Drug delivery; Nanoparticle-Based Therapies; Imaging And Diagnostics
  • 3) By Neurological Diseases: Nanoparticle-Based Drug Delivery; Diagnostic Tools
  • 4) By Orthopedic Diseases: Bone regeneration And Repair; Drug Delivery Systems
  • 5) By Infectious Diseases: Antimicrobial Nanomaterials; Vaccine Delivery Systems
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson Inc.; Abbott Laboratories; Merck & Company Inc.; Union Chimique Belge S. A
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Healthcare Nanotechnology Market Characteristics

3. Healthcare Nanotechnology Market Trends And Strategies

4. Healthcare Nanotechnology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Healthcare Nanotechnology Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Healthcare Nanotechnology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Healthcare Nanotechnology Market Growth Rate Analysis
  • 5.4. Global Healthcare Nanotechnology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Healthcare Nanotechnology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Healthcare Nanotechnology Total Addressable Market (TAM)

6. Healthcare Nanotechnology Market Segmentation

  • 6.1. Global Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiovascular Diseases
  • Oncological Diseases
  • Neurological Diseases
  • Orthopedic Diseases
  • Infectious Diseases
  • 6.2. Global Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Organic
  • Inorganic
  • Carbon-Based
  • 6.3. Global Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Delivery
  • Biomaterials
  • Active Implants
  • Tissue Regeneration
  • 6.4. Global Healthcare Nanotechnology Market, Sub-Segmentation Of Cardiovascular Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Delivery Systems
  • Diagnostic Imaging
  • 6.5. Global Healthcare Nanotechnology Market, Sub-Segmentation Of Oncological Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Targeted Drug delivery
  • Nanoparticle-Based Therapies
  • Imaging And Diagnostics
  • 6.6. Global Healthcare Nanotechnology Market, Sub-Segmentation Of Neurological Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nanoparticle-Based Drug Delivery
  • Diagnostic Tools
  • 6.7. Global Healthcare Nanotechnology Market, Sub-Segmentation Of Orthopedic Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bone regeneration And Repair
  • Drug Delivery Systems
  • 6.8. Global Healthcare Nanotechnology Market, Sub-Segmentation Of Infectious Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Antimicrobial Nanomaterials
  • Vaccine Delivery Systems

7. Healthcare Nanotechnology Market Regional And Country Analysis

  • 7.1. Global Healthcare Nanotechnology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Healthcare Nanotechnology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Healthcare Nanotechnology Market

  • 8.1. Asia-Pacific Healthcare Nanotechnology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Healthcare Nanotechnology Market

  • 9.1. China Healthcare Nanotechnology Market Overview
  • 9.2. China Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Healthcare Nanotechnology Market

  • 10.1. India Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Healthcare Nanotechnology Market

  • 11.1. Japan Healthcare Nanotechnology Market Overview
  • 11.2. Japan Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Healthcare Nanotechnology Market

  • 12.1. Australia Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Healthcare Nanotechnology Market

  • 13.1. Indonesia Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Healthcare Nanotechnology Market

  • 14.1. South Korea Healthcare Nanotechnology Market Overview
  • 14.2. South Korea Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Healthcare Nanotechnology Market

  • 15.1. Western Europe Healthcare Nanotechnology Market Overview
  • 15.2. Western Europe Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Healthcare Nanotechnology Market

  • 16.1. UK Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Healthcare Nanotechnology Market

  • 17.1. Germany Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Healthcare Nanotechnology Market

  • 18.1. France Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Healthcare Nanotechnology Market

  • 19.1. Italy Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Healthcare Nanotechnology Market

  • 20.1. Spain Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Healthcare Nanotechnology Market

  • 21.1. Eastern Europe Healthcare Nanotechnology Market Overview
  • 21.2. Eastern Europe Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Healthcare Nanotechnology Market

  • 22.1. Russia Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Healthcare Nanotechnology Market

  • 23.1. North America Healthcare Nanotechnology Market Overview
  • 23.2. North America Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Healthcare Nanotechnology Market

  • 24.1. USA Healthcare Nanotechnology Market Overview
  • 24.2. USA Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Healthcare Nanotechnology Market

  • 25.1. Canada Healthcare Nanotechnology Market Overview
  • 25.2. Canada Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Healthcare Nanotechnology Market

  • 26.1. South America Healthcare Nanotechnology Market Overview
  • 26.2. South America Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Healthcare Nanotechnology Market

  • 27.1. Brazil Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Healthcare Nanotechnology Market

  • 28.1. Middle East Healthcare Nanotechnology Market Overview
  • 28.2. Middle East Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Healthcare Nanotechnology Market

  • 29.1. Africa Healthcare Nanotechnology Market Overview
  • 29.2. Africa Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Healthcare Nanotechnology Market Competitive Landscape And Company Profiles

  • 30.1. Healthcare Nanotechnology Market Competitive Landscape
  • 30.2. Healthcare Nanotechnology Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Johnson & Johnson Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Merck & Company Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Union Chimique Belge S. A Overview, Products and Services, Strategy and Financial Analysis

31. Healthcare Nanotechnology Market Other Major And Innovative Companies

  • 31.1. Teva Pharmaceutical Industries Ltd.
  • 31.2. Sanofi SA
  • 31.3. Taiwan Liposome Company Ltd.
  • 31.4. GE Healthcare Technologies Inc.
  • 31.5. Mallinckrodt plc
  • 31.6. Leadiant Biosciences
  • 31.7. Luminex Corporation
  • 31.8. Bristol-Myers Squibb Company
  • 31.9. CytImmune Sciences Inc.
  • 31.10. Nanobiotix
  • 31.11. Starpharma Holdings Limited
  • 31.12. Copernicus Therapeutics Inc.
  • 31.13. NanoCarrier Co. Ltd
  • 31.14. LiPlasome Pharma ApS
  • 31.15. Nami Therapeutics Corp.

32. Global Healthcare Nanotechnology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Healthcare Nanotechnology Market

34. Recent Developments In The Healthcare Nanotechnology Market

35. Healthcare Nanotechnology Market High Potential Countries, Segments and Strategies

  • 35.1 Healthcare Nanotechnology Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Healthcare Nanotechnology Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Healthcare Nanotechnology Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer